Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: Long-term results in 172 patients treated in a single institution

Journal of Clinical Oncology

Volumn 23, Issue 34, 2005, Pages 8863-8869

  Combs, Stephanie E ^a   Thilmann, Christoph ^a   Edler, Lutz ^a   Debus, Jürgen ^a   Schulz Ertner, Daniela ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; CLINICAL TRIAL; FEMALE; GLIOBLASTOMA; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NEUROSURGERY; PRIORITY JOURNAL; STEREOTAXIC SURGERY; TREATMENT OUTCOME; TUMOR RECURRENCE; CANCER STAGING; CENTRAL NERVOUS SYSTEM TUMOR; CLASSIFICATION; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; EVALUATION; FOLLOW UP; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PRESCHOOL CHILD; RADIOSURGERY; STANDARD; TIME;

ADOLESCENT; ADULT; AGED; ASTROCYTOMA; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GLIOBLASTOMA; GLIOMA; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOSURGERY; TIME FACTORS; TREATMENT OUTCOME;

EID: 33644845466     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.03.4157     Document Type: Article

References (49)

1. Salford LG, Brun A, Nirfalk S: Ten-year survival among patients with supratentorial astrocytomas grade III and IV. J Neurosurg 69:506-509, 1988
2. Combs SE, Gutwein S, Thilmann C, et al: Stereotactically guided fractionated re-irradiation in recurrent glioblastoma multiforme. J Neurooncol 74:167-171, 2005
3. Combs SE, Ahmadi R, Schulz-Ertner D, et al: Recurrent low-grade gliomas: The role of fractionated stereotactic re-irradiation. J Neurooncol 71:319-323, 2005
4. Wallner KE, Galicich JH, Krol G, et al: Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 16:1405-1409, 1989
5. Dirks P, Bernstein M, Muller PJ, et al: The value of reoperation for recurrent glioblastoma. Can J Surg 36:271-275, 1993
6. B. Harsh GR, Levin VA, Gutin PH, et al: Reoperation for recurrent glioblastoma and anaplastic astrocytoma. Neurosurgery 21:615-621, 1987
7. Brandes AA, Fiorentino MV: The role of chemotherapy in recurrent malignant gliomas: An overview. Cancer Invest 14:551-559, 1996
8. Brem H, Piantadosi S, Burger PC, et al: Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group. Lancet 345:1008-1012, 1995
9. Rajan B, Ross G, Lim CC, et al: Survival in patients with recurrent glioma as a measure of treatment efficacy: Prognostic factors following nitrosourea chemotherapy. Eur J Cancer 30A:1809-15, 1994
10. Cho KH, Hall WA, Gerbi BJ, et al: Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas. Int J Radiat Oncol Biol Phys 45:1133-1141, 1999
11. Hall WA, Djalilian HR, Sperduto PW, et al: Stereotactic radiosurgery for recurrent malignant gliomas. J Clin Oncol 13:1642-1648, 1995
12. Schulz-Ertner D, Frank C, Herfarth KK, et al: Fractionated stereotactic radiotherapy for craniopharyngiomas. Int J Radiat Oncol Biol Phys 54:1114-1120, 2002
13. Kleihues P, Burger PC, Scheithauer BW: The new WHO classification of brain tumours. Brain Pathol 3:255-268, 1993
14. Menke M, Hirschfeld F, Mack T, et al: Photogrammetric accuracy measurements of head holder systems used for fractionated radiotherapy. Int J Radiat Oncol Biol Phys 29:1147-1155, 1994
15. Gademann G, Schlegel W, Debus J, et al: Fractionated stereotactically guided radiotherapy of head and neck tumors: A report on clinical use of a new system in 195 cases. Radiother Oncol 29:205-213, 1993
16. Clark TG, Bradburn MJ, Love SB, et al: Survival analysis part I: Basic concepts and first analyses. Br J Cancer 89:232-238, 2003
17. Clark TG, Bradburn MJ, Love SB, et al: Survival analysis part IV: Further concepts and methods in survival analysis. Br J Cancer 89:781-786, 2003
18. Stupp R, Mason WP, van den Bent MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996, 2005
19. Combs SE, Gutwein S, Schulz-Ertner D, et al: Temozolomide combined with radiation as postoperative treatment of primary glioblastoma multiforme: Phase I/II study. Strahlenther Onkol 181:372-377, 2005
20. Sneed PK, Gutin PH, Larson DA, et al: Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost. Int J Radiat Oncol Biol Phys 29:719-727, 1994
21. Brada M, Judson I, Beale P, et al: Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies. Br J Cancer 81:1022-1030, 1999
22. Brandes AA, Ermani M, Basso U, et al: Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: A phase II study. Ann Oncol 12:255-257, 2001
23. Levin VA, Silver P, Hannigan J, et al: Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Int J Radiat Oncol Biol Phys 18:321-324, 1990
24. Korones DN, Benita-Weiss M, Coyle TE, et al: Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma. Cancer 97:1963-1968, 2003
25. A. Sneed PK, Stauffer PR, Gutin PH, et al: Interstitial irradiation and hyperthermia for the treatment of recurrent malignant brain tumors. Neurosurgery 28:206-215, 1991
26. B. Bauman GS, Sneed PK, Wara WM, et al: Reirradiation of primary CNS tumors. Int J Radiat Oncol Biol Phys 36:433-441, 1996
27. C. Shibamoto Y, Yamashita J, Takahashi M, Abe M: Intraoperative radiation therapy for brain tumors with emphasis on retreatment for recurrence following full-dose external beam irradiation. Am J Clin Oncol 17:396-399, 1994
28. D. Arcicasa M, Roncadin M, Bidoli E, et al: Reirradiation and lomustine in patients with relapsed high-grade gliomas. Int J Radiat Oncol Biol Phys 43:789-793, 1999
29. E. Combs SE, Schulz-Ertner D, Thilmann C, et al: Re-irradiation in recurrent grade III astrocytomas using fractionated stereotactic radiotherapy (FSRT). Strahlentherapie und Onkologie (in press)
30. F. Selch MT, De Salles AAF, Solberg TD, et al: Hypofractionated stereotactic radiotherapy for recurrent malignant gliomas. J Radiosurg 3:3-12. 2000
31. G. Sanghavi S, Skrupky R, Badic B, et al: Recurrent malignant gliomas treated with radiosurgery. J Radiosurg 2:119-125, 1999
32. H. Kim HK, Thornton AF, Greenberg HS, et al: Results of reirradiation of primary intracranial neoplasms with three-dimensional conformal therapy. Am J Clin Oncol 20:358-363, 1996
33. Voynov G, Kaufman S, Hong T, et al: Treatment of recurrent malignant gliomas with stereotactic intensity modulated radiation therapy. Am J Clin Oncol 25:606-611, 2002
34. J. Park JL, Suh JH, Barnett GH, et al: Survival after stereotactic radiosurgery for recurrent glioblastoma multiforme. J Radiosurg 3:169-175, 2000
35. Baumann GS, Wara WM, Larson DA, et al: Gamma knife radiosurgery in children. Pediatr Neurosurg 24:193-201, 1996
36. Shrieve DC, Alexander E III, Wen PY, et al: Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. Neurosurgery 36:275-282, 1995
37. Leibel SA, Gutin PH, Wara WM, et al: Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 17:1129-1139, 1989
38. Halligan JB, Stelzer KJ, Rostomily RC, et al: Operation and permanent low activity 1251 brachytherapy for recurrent high-grade astrocytomas. Int J Radiat Oncol Biol Phys 35:541-547, 1996
39. Chan TA, Weingart JD, Parisi M, et al: Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy. Int J Radiat Oncol Biol Phys 62:1133-1139, 2005
40. Westphal M, Hilt DC, Bortey E, et al: A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro-oncol 5:79-88, 2003
41. McDermott MW, Berger MS, Kunwar S, et al: Stereotactic radiosurgery and interstitial brachytherapy for glial neoplasms. J Neurooncol 69:83-100, 2004
42. Chamberlain MC, Barba D, Kormanik P, et al: Stereotactic radiosurgery for recurrent gliomas. Cancer 74:1342-1347, 1994
43. Shaw E, Scott C, Souhami L, et al: Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: Final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 47:291-298, 2000
44. Combs SE, Widmer V, Thilman C, et al: Stereotactic Radiosurgery (SRS): Treatment Option for Recurrent Glioblastoma multiforme (GBM). Cancer 104:2168-2173, 2005
45. Combs SE, Schulz-Ertner D, Thilmann C, et al: Treatment of cerebral metastases from breast cancer with stereotactic radiosurgery. Strahlenther Onkol 180:590-596, 2004
46. Hudes RS, Corn BW, Werner-Wasik M, et al: A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma. Int J Radiat Oncol Biol Phys 43:293-298, 1999
47. Shepherd SF, Laing RW, Cosgrove VP, et al: Hypofractionated stereotactic radiotherapy in the management of recurrent glioma. Int J Radiat Oncol Biol Phys 37:393-398, 1997
48. Veninga T, Langendijk HA, Slotman BJ, et al: Reirradiation of primary brain tumours: Survival, clinical response and prognostic factors. Radiother Oncol 59:127-137, 2001
49. Weller M, Muller B, Koch R, et al: Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma. J Clin Oncol 21:3276-3284, 2003